November 2 Research Roundup: Skinny Mice, Why Weed Affects Women Differently Than Men, and How a Virus Kills Cancer CellsAllbiopro2018-11-03T14:07:36+09:0011월 3rd, 2018|
A Llama Antibody Could Be the Key to a Universal Flu VaccineAllbiopro2018-11-03T14:06:42+09:0011월 3rd, 2018|
AbbVie Follows Trend of Big Pharma Setting Office-Labs in Biotech ClustersAllbiopro2018-11-03T14:05:49+09:0011월 3rd, 2018|
Illumina Acquires Pacific Biosciences for $1.2 BillionAllbiopro2018-11-03T14:05:23+09:0011월 3rd, 2018|
FDA Advisors Overwhelmingly Reject Alkermes Depression DrugAllbiopro2018-11-03T14:04:57+09:0011월 3rd, 2018|
Epidiolex rollout: $32,500 list price spurs critics as first cannabis drug hits shelvesAllbiopro2018-11-03T14:04:31+09:0011월 3rd, 2018|
FiercePharmaAsia—Genentech espionage case; Astellas’ gene and cell investment; Takeda earningsAllbiopro2018-11-03T14:04:04+09:0011월 3rd, 2018|
Celgene lines up for $600M Revlimid boost as Rituxan combo scores in lymphomaAllbiopro2018-11-03T14:03:35+09:0011월 3rd, 2018|
Tale of 2 CEOs: Merck chief treads carefully on pricing, while Pfizer’s Read predicts more hikesAllbiopro2018-11-03T14:03:09+09:0011월 3rd, 2018|
Shire’s Takhzyro gets off to hot start, boosting immunology sales ahead of Takeda buyoutAllbiopro2018-11-03T14:02:41+09:0011월 3rd, 2018|
Omeicos raises €17M to run phase 2 atrial fibrillation trialAllbiopro2018-11-03T14:02:14+09:0011월 3rd, 2018|
FDA panel slams Alkermes’ opioid-based depression drugAllbiopro2018-11-03T14:01:47+09:0011월 3rd, 2018|
Illumina buys PacBio to shore up DNA sequencing dominanceAllbiopro2018-11-03T14:01:21+09:0011월 3rd, 2018|
GSK to ramp-up Shingrix vaccine as demand outstrips supplyAllbiopro2018-11-03T14:00:55+09:0011월 3rd, 2018|
Q3 saw $1.5bn in biotech IPOs, and no slowdown in sightAllbiopro2018-11-03T14:00:29+09:0011월 3rd, 2018|
